Abstract:Background and purpose: Gene transfer with recombinant non-viral vectors encoding vasodilator proteins, Such as endothelial nitric oxide synthase (eNOS), may be a preferential choice in gene therapy of artery restenosis following angioplasty, stent or anastomosis. However, the transfection rate of a non-viral vector, the harmful effects of eNOS transfection on endothelial cells (EC)and the control release of nitric oxide (NO) have been controversial. We designed the eukaryotic expression vector pcDNA3.1-eNOS to study the regulated expression of eNOS (in the presence of various chemical agents) and to evaluate the exogenous NO effect on EC proliferation in vitro.Methods: The full-length human eNOS cDNA was inserted into the EcoRI cloning site of the pcDNA3.1 expression plasmid and the eNOS direction was tested by restriction enzyme digestion with XhoI to construct recombinant pcDNA3.1-eNOS. After co-transfection of pcDNA3.1-eNOS with pcDNA3.0-EGFP mediated by cationic liposomes into Human umbilical vein endothelial cells (ECV304), the transfection rate and the effect on ECV304 proliferation were calculated by fluorescence microscopy and flowcytometry. eNOS mRNA and protein were detected by reverse transcription-PCR (RT-PCR) and immunofluorescence, respectively. The eNOS activity, NO release and changes of the relevant cells growth curve were assessed after treating the transfected cells with four independent factors including ie Ca2+, L-arginine (L-Arg), Ethylene Diamine Tetraacetic Acid (EDTA) and N-nitro-L-arginine methylester (L-NAME). In addition, we examined the nontransfected cells status by isolated sodium nitroprusside (SNP) treatment.Result: eNOS cDNA was inserted into pcDNA3.1 in die proper direction. RT-PCR analysis showed that pcDNA3.1-eNOS transfected cells could express eNOS mRNA. The rate of eNOS transfection was 39.6 +/- 3.4%. Immunofluorescence staining displayed that subcellular localisation of eNOS was most prominent in plasma membrane and per] nuclear regions of the cell. The eNOS activity of eNOS transfected cells had not increased significantly, whereas, in the presence of Call, L-Arg, EDTA, and L-NAME, the eNOS activity was 96.98 +/- 13.47, 32.57 +/- 6.39, 11.63 +/- 3.02, 15.56 +/- 7.34 U/ml respectively and the NO level was 55.34 +/- 11.19, 9.43 +/- 4.51., 2.63 +/- 1.41, 3.73 +/- 1.65 mmol/L, respectively. Meanwhile, die growth curves of EC shifted. SNP also had obvious growth-inhibiting effects on the cells. Together, the ECV304 growth curve went downward in a NO concentration-dependent manner.Conclusion: Eukaryotic expression vector pcDNA3.1-eNOS was constructed successfully with the ability to express human eNOS mRNA and protein in EC effectively. The activity of eNOS in EC could be regulated by certain exogenous factors. Ca2+ was an important factor promoting NO release and excess NO had a cytotoxic effect on EC in vitro. Controlled release of NO in vivo and polygenic measurements might be considered in more clinical gene therapy studies.

Effect of Enos Gene Transfer on the Capacity of Hepatic Sinusoids in cirrhotic rats

Effects of Enos Gene Transfer on the Expression of Enos and Portal Hypertension in Cirrhotic Rats

Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.

[Experimental study on iNOS gene transfer mediated by liposome to treat portal hypertension in cirrhotic rats]

Vascular Endothelial Growth Factor Attenuates Hepatic Sinusoidal Capillarization in Thioacetamide-Induced Cirrhotic Rats

Angiogenesis Effect on Rat Liver after Administration of Expression Vector Encoding Vascular Endothelial Growth Factor D

The Effect on Liver Fibrosis and Portal Pressure after Administration of Expression Vector Encoding for Endothelial Growth Factor D in Biliary Cirrhotic Rats

The eNOS gene expression of hepatocytes in the process of liver regeneration using RT-PCR

Akt Gene Therapy for Cirrhotic Rats with Portal Hypertension

Protective Effect of Enos Overexpression Against Ischemia/reperfusion Injury in Small-for-size Liver Transplantation.

Role of Intra-Hepatic Injection of Naked PCHPO/hVEGF-D in Promoting Angiogenesis in Rats

Study on Inhibittonal Effect of Endothelial Nitric Oxide Synthase Gent Transfer on Neointimal Proliferation of Artery after Hal-Ion Injury

Influence of Enos Gene Transfection on the Extent of Re-stricture of the Common Carotid Artery after Injury in Rat

Effects of endothelial nitric oxide synthase gene transfection on neointima hyperplasia after vascular injury

Experimental Study of Recombinant Aukaryotic Expression Vector of Human Enos in ECV304 Cells

Early Expression of Inducible Nitric Oxide Synthase in Lung of the Rat with Different Size Graft Liver Transplantation

The Effect of Endothelial Progenitor Cell Transplantation on Liver Cirrhosis in Rats

Effects of Adenovirus-Mediated Endothelial Nitric Oxide Synthase Gene Transfer on Neointimal Proliferation of Rat Carotid Artery after Balloon Injury

Enos Gene Transfection on Pulmonary Artery Hypertension and Hypertension Crisis in Rabbits

Effects of ET-1 and NO on hepatic hemodynamics at various stages of isolated perfused cirrhotic liver in rats

Influence of Nitric Oxide and Endothelin on Levels of Liver Function and Portal Hyperdynamics in Patients with Liver Cirrhosis